HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N Takahashi Selected Research

Krypton-81

11/2000Beneficial effect of combination therapy with ozagrel and pranlukast in exercise-induced asthma demonstrated by krypton-81 m ventilation scintigraphy--a case report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


N Takahashi Research Topics

Disease

29Neoplasms (Cancer)
10/2020 - 01/2000
10Inflammation (Inflammations)
10/2018 - 02/2000
7BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2017 - 12/2000
6Bone Resorption
10/2016 - 01/2000
6Lung Neoplasms (Lung Cancer)
01/2016 - 01/2000
6Fibrosis (Cirrhosis)
03/2012 - 12/2000
6Dental Plaque
08/2009 - 04/2001
5Periodontal Diseases (Periodontal Disease)
01/2022 - 12/2001
5Periodontitis
01/2022 - 02/2010
5Necrosis
12/2012 - 01/2001
5Infections
02/2010 - 03/2003
5Pain (Aches)
09/2007 - 12/2000
5Body Weight (Weight, Body)
11/2002 - 03/2000
5Breast Neoplasms (Breast Cancer)
11/2001 - 02/2000
5Heart Failure
11/2001 - 05/2000
5Neoplasm Metastasis (Metastasis)
10/2001 - 03/2000
4Hypertension (High Blood Pressure)
01/2022 - 01/2000
4Dental Caries (Decay, Dental)
12/2015 - 12/2010
4Lymphoma (Lymphomas)
08/2011 - 01/2000
4Ischemia
11/2009 - 03/2001
4Reperfusion Injury
01/2005 - 03/2001
3Hemorrhage
10/2020 - 03/2001
3Colorectal Neoplasms (Colorectal Cancer)
08/2017 - 05/2000
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2016 - 03/2001
3Obesity
05/2015 - 12/2000
3Hepatocellular Carcinoma (Hepatoma)
06/2014 - 09/2001
3Diarrhea
07/2012 - 06/2001
3Adenocarcinoma
06/2012 - 05/2000
3Cysts
05/2009 - 05/2002
3Endometrial Neoplasms (Endometrial Cancer)
12/2007 - 12/2006
3Glomerulonephritis
11/2007 - 05/2000
3Empyema
12/2005 - 10/2004
3Fever (Fevers)
12/2005 - 12/2000
3Asthma (Bronchial Asthma)
09/2005 - 02/2000
3Fistula
03/2005 - 10/2004
3Leukemia
11/2001 - 02/2000
3Prostatic Neoplasms (Prostate Cancer)
11/2001 - 09/2000
3Myocardial Ischemia (Ischemic Heart Diseases)
07/2001 - 01/2001
3Carcinoma (Carcinomatosis)
12/2000 - 09/2000
2Esophageal Neoplasms (Esophageal Cancer)
01/2021 - 01/2020
2Chronic Periodontitis
06/2018 - 02/2010
2Bacterial Infections (Bacterial Infection)
06/2018 - 12/2005
2Insulin Resistance
10/2016 - 07/2006
2Autoimmune Diseases (Autoimmune Disease)
06/2014 - 07/2002
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
02/2014 - 11/2007
2Fibrosarcoma
01/2014 - 09/2001
2Type 2 Diabetes Mellitus (MODY)
11/2012 - 01/2007
2Stomach Neoplasms (Stomach Cancer)
06/2012 - 06/2010
2Lymphatic Metastasis
06/2012 - 07/2007
2Pneumonia (Pneumonitis)
06/2012 - 10/2001
2Schizophrenia (Dementia Praecox)
05/2011 - 06/2006

Drug/Important Bio-Agent (IBA)

15Proteins (Proteins, Gene)FDA Link
12/2015 - 01/2000
8AcidsIBA
01/2022 - 04/2001
8Pharmaceutical PreparationsIBA
10/2020 - 05/2000
6Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2022 - 01/2000
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2012 - 01/2000
6AntigensIBA
09/2011 - 05/2000
6Messenger RNA (mRNA)IBA
01/2003 - 01/2000
5LigandsIBA
05/2014 - 10/2000
4C-Reactive ProteinIBA
06/2018 - 05/2000
4DNA (Deoxyribonucleic Acid)IBA
01/2017 - 01/2000
4AntibodiesIBA
05/2014 - 05/2000
4SugarsIBA
12/2011 - 04/2001
4Doxorubicin (Adriamycin)FDA LinkGeneric
08/2011 - 08/2001
3CholesterolIBA
06/2018 - 03/2000
3Biomarkers (Surrogate Marker)IBA
06/2018 - 01/2000
3Interleukin-6 (Interleukin 6)IBA
10/2016 - 02/2010
3CarbohydratesIBA
12/2015 - 11/2003
3Imatinib Mesylate (Gleevec)FDA Link
04/2015 - 06/2008
3Biological ProductsIBA
02/2014 - 09/2001
3Glucose (Dextrose)FDA LinkGeneric
12/2012 - 12/2001
3Immunoglobulin G (IgG)IBA
11/2007 - 07/2002
3Insulin (Novolin)FDA Link
03/2007 - 11/2002
3Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
12/2006 - 07/2002
3CytokinesIBA
01/2006 - 08/2001
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2004 - 08/2001
3Atrial Natriuretic Factor (ANF)IBA
08/2002 - 09/2000
3Monoclonal AntibodiesIBA
11/2001 - 03/2001
3Fluorouracil (Carac)FDA LinkGeneric
09/2001 - 05/2000
3NF-kappa B (NF-kB)IBA
07/2001 - 02/2000
3Carrier Proteins (Binding Protein)IBA
04/2001 - 01/2000
2NitritesIBA
01/2022 - 12/2015
2NitratesIBA
01/2022 - 12/2015
2Indicators and Reagents (Reagents)IBA
01/2021 - 12/2006
2Tyrosine Kinase InhibitorsIBA
01/2017 - 04/2015
2MicroRNAs (MicroRNA)IBA
01/2016 - 08/2011
2Complementary DNA (cDNA)IBA
06/2014 - 09/2000
2TRPA1 Cation ChannelIBA
04/2014 - 12/2008
2Protein Kinases (Protein Kinase)IBA
12/2012 - 11/2012
2AutoantigensIBA
09/2011 - 07/2002
2RNA (Ribonucleic Acid)IBA
08/2011 - 05/2004

Therapy/Procedure

20Therapeutics
01/2017 - 01/2000
15Drug Therapy (Chemotherapy)
04/2015 - 03/2000
4Radiotherapy
01/2021 - 10/2000
4Transplantation
06/2014 - 11/2001
4Lymph Node Excision (Lymph Node Dissection)
06/2010 - 03/2001
4Renal Dialysis (Hemodialysis)
10/2004 - 12/2000
3Thoracotomy
10/2003 - 03/2001
3Bone Marrow Transplantation (Transplantation, Bone Marrow)
05/2001 - 11/2000
2Neoadjuvant Therapy
01/2021 - 01/2020